In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target.


Journal

Blood cancer discovery
ISSN: 2643-3249
Titre abrégé: Blood Cancer Discov
Pays: United States
ID NLM: 101764786

Informations de publication

Date de publication:
01 05 2023
Historique:
received: 17 05 2022
revised: 30 11 2022
accepted: 06 02 2023
medline: 2 5 2023
pubmed: 11 2 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

Acute myeloid leukemia (AML) is fueled by leukemic stem cells (LSC) whose determinants are challenging to discern from hematopoietic stem cells (HSC) or uncover by approaches focused on general cell properties. We have identified a set of RNA-binding proteins (RBP) selectively enriched in human AML LSCs. Using an in vivo two-step CRISPR-Cas9 screen to assay stem cell functionality, we found 32 RBPs essential for LSCs in MLL-AF9;NrasG12D AML. Loss-of-function approaches targeting key hit RBP ELAVL1 compromised LSC-driven in vivo leukemic reconstitution, and selectively depleted primitive malignant versus healthy cells. Integrative multiomics revealed differentiation, splicing, and mitochondrial metabolism as key features defining the leukemic ELAVL1-mRNA interactome with mitochondrial import protein, TOMM34, being a direct ELAVL1-stabilized target whose repression impairs AML propagation. Altogether, using a stem cell-adapted in vivo CRISPR screen, this work demonstrates pervasive reliance on RBPs as regulators of LSCs and highlights their potential as therapeutic targets in AML. LSC-targeted therapies remain a significant unmet need in AML. We developed a stem-cell-adapted in vivo CRISPR screen to identify key LSC drivers. We uncover widespread RNA-binding protein dependencies in LSCs, including ELAVL1, which we identify as a novel therapeutic vulnerability through its regulation of mitochondrial metabolism. This article is highlighted in the In This Issue feature, p. 171.

Identifiants

pubmed: 36763002
pii: 716497
doi: 10.1158/2643-3230.BCD-22-0086
pmc: PMC10150294
doi:

Substances chimiques

RNA-Binding Proteins 0
TOMM34 protein, human 0
Mitochondrial Precursor Protein Import Complex Proteins 0
ELAVL1 protein, human 0
ELAV-Like Protein 1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

180-207

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL137223
Pays : United States

Informations de copyright

©2023 The Authors; Published by the American Association for Cancer Research.

Références

Nat Rev Genet. 2014 Oct;15(10):689-701
pubmed: 25112293
Blood. 2017 Mar 9;129(10):1260-1269
pubmed: 27940478
Cancer Cell. 2018 Mar 12;33(3):386-400.e5
pubmed: 29478914
Cell Stem Cell. 2013 Mar 7;12(3):329-41
pubmed: 23333149
EMBO J. 1998 Jun 15;17(12):3448-60
pubmed: 9628880
Genes Dis. 2017 Nov 21;5(1):27-35
pubmed: 30258932
Mol Cell. 2011 Aug 5;43(3):327-39
pubmed: 21723170
Cancer Res. 2001 Mar 1;61(5):2154-61
pubmed: 11280780
Mol Biol Cell. 2015 May 15;26(10):1797-810
pubmed: 25808495
Cancer Discov. 2021 May;11(5):1052-1066
pubmed: 33504581
Nat Protoc. 2014 Jan;9(1):171-81
pubmed: 24385147
Biochim Biophys Acta Gene Regul Mech. 2018 Feb;1861(2):167-177
pubmed: 29413897
Sci Rep. 2017 May 19;7(1):2172
pubmed: 28526879
Cancer Cell. 2019 Mar 18;35(3):369-384.e7
pubmed: 30799057
Cell. 2016 Apr 7;165(2):303-16
pubmed: 27058663
EMBO J. 1998 Jun 15;17(12):3461-70
pubmed: 9628881
Blood. 2013 Oct 24;122(17):3034-44
pubmed: 23970380
Cell Stem Cell. 2016 Aug 4;19(2):177-191
pubmed: 27292188
Cell Stem Cell. 2016 Jul 7;19(1):23-37
pubmed: 27374788
Nat Methods. 2016 Jun;13(6):508-14
pubmed: 27018577
Nat Commun. 2018 Jun 7;9(1):2213
pubmed: 29880812
Nat Med. 2016 Jul;22(7):792-9
pubmed: 27322744
Cancer Res. 1998 Dec 15;58(24):5818-24
pubmed: 9865741
Cancer Res. 2017 May 1;77(9):2424-2438
pubmed: 28428272
Blood. 2008 Nov 15;112(10):4193-201
pubmed: 18716133
RNA Biol. 2018 Jan 2;15(1):115-129
pubmed: 29023197
J Surg Res. 2012 Nov;178(1):155-64
pubmed: 22626558
Nat Commun. 2014;5:3078
pubmed: 24452013
Nucleic Acids Res. 2016 Jan 4;44(D1):D917-24
pubmed: 26507857
Nature. 2017 Jul 6;547(7661):104-108
pubmed: 28658204
Science. 2020 Mar 13;367(6483):1264-1269
pubmed: 32165588
CRISPR J. 2022 Feb;5(1):123-130
pubmed: 35119294
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Cell Stem Cell. 2012 Sep 7;11(3):359-72
pubmed: 22863534
Blood. 2017 May 4;129(18):2493-2506
pubmed: 28232582
J Biol Chem. 2020 Jul 3;295(27):8928-8944
pubmed: 32371396
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7622-7
pubmed: 12032333
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2987-92
pubmed: 14981256
Oncogene. 1999 Jun 17;18(24):3574-82
pubmed: 10380879
Nat Med. 2011 Aug 28;17(9):1086-93
pubmed: 21873988
Cancer Discov. 2022 Feb;12(2):432-449
pubmed: 34531254
Nat Chem Biol. 2007 Aug;3(8):508-15
pubmed: 17632515
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2794-9
pubmed: 16477019
Nat Cancer. 2020 Apr;1(4):410-422
pubmed: 34109316
Nat Rev Genet. 2014 Dec;15(12):829-45
pubmed: 25365966
Mol Cancer. 2018 Aug 28;17(1):130
pubmed: 30153828
Cancer Cell. 2006 Oct;10(4):257-68
pubmed: 17045204
Front Oncol. 2021 Apr 01;11:587479
pubmed: 33868990
Cancer Res. 2011 Mar 15;71(6):2172-82
pubmed: 21252116
Blood. 2003 Apr 15;101(8):3142-9
pubmed: 12468427
Leukemia. 2017 Jan;31(1):143-150
pubmed: 27211268
Nature. 2016 Apr 28;532(7600):508-511
pubmed: 27121842
Genes Dev. 2016 Nov 15;30(22):2459-2474
pubmed: 27940961
Blood. 2014 Feb 6;123(6):894-904
pubmed: 24363398
Biomed Res Int. 2017;2017:9596152
pubmed: 28191469
Cell. 2017 Feb 23;168(5):890-903.e15
pubmed: 28162770
Cell Stem Cell. 2010 Jul 2;7(1):101-13
pubmed: 20621054
Nat Med. 2017 Nov;23(11):1369-1376
pubmed: 28920958
Genome Biol. 2014;15(12):554
pubmed: 25476604
Blood. 2009 Mar 26;113(13):3088-91
pubmed: 19171880
Cancer Cell. 2013 Jul 8;24(1):45-58
pubmed: 23770013
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Stem Cell Reports. 2014 Nov 11;3(5):858-75
pubmed: 25418729
Nat Med. 2017 Oct;23(10):1234-1240
pubmed: 28920959
Blood. 2013 Jun 6;121(23):4627-34
pubmed: 23568491
Nature. 2011 Aug 03;478(7370):524-8
pubmed: 21814200
Cancer Cell. 2018 Nov 12;34(5):724-740.e4
pubmed: 30423294
PLoS One. 2010 Nov 11;5(11):e15499
pubmed: 21124907
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Mol Cell Proteomics. 2016 May;15(5):1710-27
pubmed: 26944342
Cell Rep. 2019 Dec 3;29(10):3101-3117.e7
pubmed: 31801076
Blood. 2016 Apr 21;127(16):2018-27
pubmed: 26834243
Br J Haematol. 2008 Sep;142(5):802-7
pubmed: 18573112
Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18309-14
pubmed: 25422430
Mol Biol Cell. 2009 Dec;20(23):4885-98
pubmed: 19812253
J Clin Invest. 2015 Mar 2;125(3):1286-98
pubmed: 25664853
Nature. 2018 Oct;562(7728):526-531
pubmed: 30333627
J Biol Chem. 2008 Jul 4;283(27):19077-84
pubmed: 18463097
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Oncogene. 2003 Oct 16;22(46):7146-54
pubmed: 14562043
Nat Rev Genet. 2007 Jul;8(7):533-43
pubmed: 17572691
N Engl J Med. 2015 Sep 17;373(12):1136-52
pubmed: 26376137
Mol Cancer Res. 2016 Jul;14(7):599-611
pubmed: 27053682
Nature. 2006 Aug 17;442(7104):818-22
pubmed: 16862118
Leukemia. 2015 Jul;29(7):1470-7
pubmed: 25976987
J Clin Invest. 2009 Dec;119(12):3530-43
pubmed: 19884656
Genome Biol. 2014 Jan 10;15(1):R14
pubmed: 24410894
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Biotechnol. 2007 Nov;25(11):1315-21
pubmed: 17952057
Cell Stem Cell. 2019 Jul 3;25(1):137-148.e6
pubmed: 31031138
Prostate. 2016 Feb 15;76(3):259-72
pubmed: 26764246
Blood Cancer J. 2018 Jan 10;8(1):4
pubmed: 29321554
Nature. 2018 Jan 25;553(7689):515-520
pubmed: 29342133
Nat Commun. 2021 Jun 7;12(1):3341
pubmed: 34099695
Cell Stem Cell. 2014 Mar 6;14(3):275-91
pubmed: 24607403
Nature. 2014 Sep 18;513(7518):382-7
pubmed: 25043054
Cell Stem Cell. 2018 Feb 1;22(2):191-205.e9
pubmed: 29290617
Nat Cell Biol. 2017 Jul;19(7):844-855
pubmed: 28650479
Nature. 2016 Dec 15;540(7633):433-437
pubmed: 27926740
Nat Biotechnol. 2015 Jun;33(6):661-7
pubmed: 25961408
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5166-71
pubmed: 18362358
Mol Cell Biol. 2009 Mar;29(5):1152-62
pubmed: 19114552
Cell Stem Cell. 2020 Jul 2;27(1):81-97.e8
pubmed: 32402251
Blood. 2006 Feb 1;107(3):924-30
pubmed: 16219798
Annu Rev Biochem. 2017 Jun 20;86:685-714
pubmed: 28301740
J Biol Chem. 2014 Apr 4;289(14):9887-901
pubmed: 24567332
Clin Cancer Res. 2004 Jul 15;10(14):4652-60
pubmed: 15269137
BMC Bioinformatics. 2009 Dec 15;10:422
pubmed: 20003504
N Engl J Med. 2018 Dec 13;379(24):2330-2341
pubmed: 30380364
Trends Endocrinol Metab. 2015 Dec;26(12):746-757
pubmed: 26520658
Blood. 2001 Oct 15;98(8):2301-7
pubmed: 11588023
Sci Rep. 2015 Nov 10;5:16478
pubmed: 26553968
Blood. 2007 Oct 1;110(7):2578-85
pubmed: 17601986
Cancer Res. 2005 Mar 15;65(6):2157-61
pubmed: 15781626

Auteurs

Ana Vujovic (A)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Laura de Rooij (L)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.

Ava Keyvani Chahi (AK)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.

He Tian Chen (HT)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.

Brian A Yee (BA)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California.

Sampath K Loganathan (SK)

Centre for Molecular and Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.

Lina Liu (L)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Derek C H Chan (DCH)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.

Amanda Tajik (A)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.

Emily Tsao (E)

Department of Medical Biophysics, University of Toronto, Toronto, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Steven Moreira (S)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Pratik Joshi (P)

Department of Medical Biophysics, University of Toronto, Toronto, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Joshua Xu (J)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.

Nicholas Wong (N)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Zaldy Balde (Z)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Soheil Jahangiri (S)

Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Sasan Zandi (S)

Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Canada.

Stefan Aigner (S)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California.

John E Dick (JE)

Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Canada.

Mark D Minden (MD)

Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Faculty of Medicine, University of Toronto, Toronto, Canada.

Daniel Schramek (D)

Centre for Molecular and Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Canada.

Gene W Yeo (GW)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California.

Kristin J Hope (KJ)

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH